BIOMAT Database Logo BIOMAT Database Logo

Influence of route of administration on antileukemic activity of cytosine arabinoside (NSC-63878) in advanced leukemia L1210 in mice. 1968

I Kline, and D D Tyrer, and M Gang, and J M Venditti, and A Goldin

UI MeSH Term Description Entries
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D008297 Male Males
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

I Kline, and D D Tyrer, and M Gang, and J M Venditti, and A Goldin
Influence of mitotic cycle inhibitors on the antileukemic activity of cytosine arabinoside (NSC-63878) in mice bearing leukemia L1210.
December 1971, Cancer chemotherapy reports,
I Kline, and D D Tyrer, and M Gang, and J M Venditti, and A Goldin
ACTIVITY OF SELECTED COMPOUNDS IN SUBLINE OF LEUKEMIA L1210 RESISTANT TO CYTOSINE ARABINOSIDE (NSC-63878).
December 1964, Cancer chemotherapy reports,
I Kline, and D D Tyrer, and M Gang, and J M Venditti, and A Goldin
Cytosine arabinoside (NSC-63878) in acute leukemia in children.
July 1966, Cancer chemotherapy reports,
I Kline, and D D Tyrer, and M Gang, and J M Venditti, and A Goldin
Influence of the stage of advancement of leukemia L1210 in mice on the optimal schedule of treatment of cytosine arabinoside (NSC-63878).
June 1972, Cancer chemotherapy reports,
I Kline, and D D Tyrer, and M Gang, and J M Venditti, and A Goldin
Effect of different doses of methotrexate (NSC-740), cytosine arabinoside (NSC-63878), and cyclophosphamide (NSC-26271) on drug resistance in mice with L1210 leukemia.
August 1972, Cancer chemotherapy reports,
I Kline, and D D Tyrer, and M Gang, and J M Venditti, and A Goldin
Cytosine arabinoside (NSC-63878)--clinical brochure.
December 1968, Cancer chemotherapy reports. Part 3,
I Kline, and D D Tyrer, and M Gang, and J M Venditti, and A Goldin
Cytosine arabinoside (NSC-63878) therapy for acute leukemia in adults.
February 1969, Cancer chemotherapy reports,
I Kline, and D D Tyrer, and M Gang, and J M Venditti, and A Goldin
Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia.
January 1973, Cancer chemotherapy reports,
I Kline, and D D Tyrer, and M Gang, and J M Venditti, and A Goldin
Comparative studies of cyclocytidine (NSC-145668) and cytosine arabinoside (NSC-63878) in mice.
January 1975, Cancer chemotherapy reports,
I Kline, and D D Tyrer, and M Gang, and J M Venditti, and A Goldin
Antitumor activity and pharmacologic disposition of cytosine arabinoside (NSC-63878).
October 1965, Cancer chemotherapy reports,
Copied contents to your clipboard!